Pontifícia Universidade Católica do Rio Grande do Sul, Hospital São Lucas, Porto Alegre RS, Brazil.
Hospital de Clínicas de Passo Fundo, Serviço de Neurologia e Neurocirurgia, Passo Fundo RS, Brazil.
Arq Neuropsiquiatr. 2021 Aug;79(8):692-696. doi: 10.1590/0004-282X-anp-2020-0221.
To improve the comparability of multiple sclerosis (MS) prevalence across Brazilian regions, the Brazilian Committee for Treatment and Research in MS has implemented a standardized approach to assess the prevalence of the disease in five key cities, which were deemed representative of their regions in terms of socio-geographical features and where in-person revision of each case was feasible.
To report the point-prevalence of MS in Passo Fundo, one of the key cities in Southern Brazil.
We sought to identify all MS patients who were living in Passo Fundo on July 1st, 2015. The primary source for case ascertainment was records from the offices of neurologists and neurosurgeons practicing in the city. Multiple secondary sources were used to maximize identification of cases. All patients underwent in-person review of the diagnosis by a panel of neurologists with experience in MS.
We identified 52 MS patients living in Passo Fundo on July 1st, 2015. The point-prevalence rate for MS was 26.4/100,000 population (95% confidence interval, 19.7 to 34.6/100,000). Among the MS cases, 42 (80.8%) were female, for a sex ratio of 4.2:1. Forty-six cases (88.5%) were categorized as relapsing-remitting MS, and the remaining 6 cases, as secondary progressive MS (11.5%). Other epidemiological and clinical features were comparable to national and international MS populations.
The prevalence of MS in Passo Fundo is one of the highest reported in Brazil so far. Studies in other key Brazilian cities, using the same methodology, are currently being carried out.
为了提高巴西各地多发性硬化症(MS)患病率的可比性,巴西 MS 治疗和研究委员会实施了一种标准化方法,以评估五个关键城市的疾病患病率,这些城市在社会地理特征方面被认为代表了其所在地区,并且可以对每个病例进行现场修订。
报告巴西南部关键城市之一帕索丰杜(Passo Fundo)的 MS 点患病率。
我们试图确定 2015 年 7 月 1 日居住在帕索丰杜的所有 MS 患者。病例确定的主要来源是在该市执业的神经科医生和神经外科医生的办公室记录。还使用了多种次要来源来最大限度地发现病例。所有患者均由具有 MS 经验的神经病学家小组进行了现场诊断复核。
我们确定了 2015 年 7 月 1 日居住在帕索丰杜的 52 名 MS 患者。MS 的时点患病率为 26.4/100,000 人(95%置信区间,19.7 至 34.6/100,000)。在 MS 病例中,42 例(80.8%)为女性,男女比例为 4.2:1。46 例(88.5%)归类为复发缓解型 MS,其余 6 例为继发进展型 MS(11.5%)。其他流行病学和临床特征与全国和国际 MS 人群相似。
帕索丰杜的 MS 患病率是巴西迄今为止报道的最高之一。目前正在使用相同的方法对巴西其他关键城市进行研究。